Literature DB >> 16858078

Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays.

Robert H Christenson1, Show Hong Duh, Fred S Apple, Geza S Bodor, David M Bunk, Mauro Panteghini, Michael J Welch, Alan H B Wu, Stephen E Kahn.   

Abstract

BACKGROUND: Cardiac tropoin I (cTnI) measurements show an approximately 20- to 40-fold difference between assays, and better standardization and harmonization are needed. Toward this goal, the AACC cTnI Standardization Committee collaborated with the National Institute of Standards and Technology (NIST) in an earlier study to select 2 candidate reference materials (cRMs).
METHODS: Two troponin cRMs, a troponin C-troponin I-troponin T (CIT) complex from human heart tissue and a CIT complex from recombinant technology, were supplied to NIST for assessment of composition and purity, and cTnI value assignment. These cRMs and 6 cTnI-positive human serum pools were shipped to manufacturers of 15 cTnI assays. Commutability of the materials was examined by determining the numerical relationship for the cRM preparations between each manufacturer-specified field method and each of the other 14 field methods. These relationships were then compared with the corresponding numerical relationships for the human serum pools. Harmonization of methods was accomplished by determining regression parameters relative to the analytical system yielding values closest to the median for each serum pool. These regression parameters were used to recalculate pool values to harmonize the assays. Interassay CVs before and after harmonization were determined.
RESULTS: Characterization of the CIT and CI cRMs showed that these materials were of specified composition. The proportion of cTnI methods that demonstrated commutability for the CIT cRM was 45%; for the CI cRM, 39% of methods demonstrated commutability. Interassay cTnI variability for the field methods ranged from 82% to 97%, median 88%. After harmonization, variability of the serum pools for the cTnI methods was decreased to between 9.0% and 23%, median 15.5%.
CONCLUSIONS: The proportion of methods demonstrating commutability was too low for use as a common calibrator for the cTnI field methods. However a simple strategy using serum pools can improve harmonization of field cTnI methods by more than 5-fold. The CIT cRM was selected by the AACC cTnI standardization committee, and a new lot has been classified as the cTnI certified reference material Standard Reference Material 2921 by NIST.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858078     DOI: 10.1373/clinchem.2006.068437

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  The Joint Committee for Traceability in Laboratory Medicine (JCTLM): a global approach to promote the standardisation of clinical laboratory test results.

Authors:  David Armbruster; Richard R Miller
Journal:  Clin Biochem Rev       Date:  2007-08

2.  Reference materials and commutability.

Authors:  Hubert W Vesper; W Gregory Miller; Gary L Myers
Journal:  Clin Biochem Rev       Date:  2007-11

3.  Reference materials and reference measurement procedures: an overview from a national metrology institute.

Authors:  David M Bunk
Journal:  Clin Biochem Rev       Date:  2007-11

4.  Standardisation of reference intervals: an Australasian view.

Authors:  Graham Jones; Antony Barker
Journal:  Clin Biochem Rev       Date:  2007-11

5.  Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator Material.

Authors:  Kyra J Cowan; Lakshmi Amaravadi; Mark J Cameron; Damien Fink; Darshana Jani; Medha Kamat; Lindsay King; Robert J Neely; Yan Ni; Paul Rhyne; Renee Riffon; Yuda Zhu
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

6.  Analytical validation of cardiac troponin I assays in horses.

Authors:  Tanya M Rossi; Peter A Kavsak; M Grant Maxie; David L Pearl; W Glen Pyle; Peter W Physick-Sheard
Journal:  J Vet Diagn Invest       Date:  2017-12-10       Impact factor: 1.279

7.  Quantification of cardiac troponin I in human plasma by immunoaffinity enrichment and targeted mass spectrometry.

Authors:  Nicole A Schneck; Karen W Phinney; Sang Bok Lee; Mark S Lowenthal
Journal:  Anal Bioanal Chem       Date:  2018-03-01       Impact factor: 4.142

8.  Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage.

Authors:  Joyce K Miketic; Marilyn Hravnak; Susan M Sereika; Elizabeth A Crago
Journal:  Am J Crit Care       Date:  2010-01-27       Impact factor: 2.228

Review 9.  Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

Authors:  S Vasikaran; R Eastell; O Bruyère; A J Foldes; P Garnero; A Griesmacher; M McClung; H A Morris; S Silverman; T Trenti; D A Wahl; C Cooper; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-24       Impact factor: 4.507

10.  Commutability of possible external quality assessment materials for cardiac troponin measurement.

Authors:  Shunli Zhang; Jie Zeng; Chuanbao Zhang; Yilong Li; Haijian Zhao; Fei Cheng; Songlin Yu; Mo Wang; Wenxiang Chen
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.